[ Home ] [ Controlled Substances ] [ Stimulants ]
NEA
|
Etilamfetamine (Apetinil) is a stimulant drug of amphetamine chemical class. It is an N-substituted amphetamine with an ethyl group on the amphetamine backbone. It was used as an anorectic or appetite suppressant. Etilamfetamine is a psychoactive drug, which can be used as a recreational drug. Etilamfetamine has been abused as a "designer drug" alternative to amphetamine and possibly methamphetamine. It is a dopamine releasing agent.
Etilamfetamine (Apetinil):
https://drugs.ncats.io/drug/022YON1XMX
https://www.caymanchem.com/msdss/11557m.pdf
It was invented in the early 20th century and was subsequently used as an anorectic or appetite suppressant in the 1950s, but was not as commonly used as other amphetamines. was largely discontinued once newer drugs such as phenmetrazine were introduced. It most likely acts primarily as a dopamine releasing agent. Its activity as a norepinephrine or serotonin releasing agent is not known. Ethylamphetamine can be used as a recreational drug and, while its prevalence is less than amphetamine's, it is still encountered as a substance taken for recreational purposes. Ethylamphetamine produces effects similar to amphetamine and methamphetamine, though its potency is less. At equipotent dosage, ethylamphetamine is subjectively less euphorigenic.
Anterior Secures $20M from NEA to Accelerate AI-Powered Health Insurance Approvals - The investment round was led by NEA, a major player in venture capital ... and Xaira, an AI-based drug discovery startup. His expertise and successful track record in healthcare investments ... Monday June 10, 2024 - msn.com Boy, 16, shot in Belleville after dispute with two teens over drugs, police say - The boy was taken to a St. Louis hospital for treatment. Belleville police did not provide an update on the boy's condition. Sanders Rips Pharma Giant for Charging $900+ for Drug That Could Be Sold for $100 - Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely. Northwest Florida leaders weigh in on Navarre incorporation ahead of straw poll - Navarre residents gathered today for a Q&A session to discuss a straw poll on incorporation set for Saturday. The meeting featured insights from Wes Siler, director of Preserve Navarre; Bobby Wagner, ... Enter Xaira, with $1bn for its AI in drug discovery platform - which reflects Xaira’s potential “to rethink drug discovery entirely.” Along with the two initial backers, the round has also been joined by F-Prime, NEA, Sequoia Capital, Lux Capital ... Nuveen AMT-Free Quality Muni Inc NEA - We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ... Here’s the full list of 39 US AI startups that have raised $100M or more in 2024 - AI startups continue to dominate the venture capital funding landscape. Here are the all the megarounds so far in 2024. NEA project skills - During the designing and making processes it is important to gather feedback from the client and users. Refining the product based on this feedback helps solve any problems before production ... 858 Therapeutics Announces $50 Million Series B Financing - About 858 Therapeutics 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule therapeutics directed against novel oncology and immunology targets. Its ... Artist and mentor, a former gang member, honored by National Endowment for the Arts - A former gang member who spent several years incarcerated, Debora was recently honored by the National Endowment for the Arts as a 2024 NEA National Heritage Fellow. He was presented the award ... Unsure if you can recycle a frying pan? Ask NEA’s new AI chatbot - The National Environment Agency’s (NEA) Bloobin AI chatbot, named after Singapore’s blue recycling mascot, was rolled out on messaging applications WhatsApp and Telegram on Sept 16. Lydia Ramsey Pflanzer - Healthcare 2023-06-07T13:19:53Z CVS and NEA just sank $166 million into a startup ... One Medical to launching RxPass, a prescription-drug service for Prime members. Reverence wants to change ...
| ||
| Stimulants | Link to this page |